PAR-24-116 - NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Interventions to Reduce Chronic Inflammation and Inflammation-Related Morbidity in People Living with HIV/AIDS | NOT-AT-24-035 | NCCIH, NIA | Mar 4, 2024 | Nov 14, 2024 | R01, R61/R33, R34, R21 |
| Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research | NOT-AI-22-004 | NIAID, NIAMS, NCCIH, NCI | Nov 23, 2021 | Jan 8, 2025 | R03, R21, U01, U44, R01, R34, P01, R61/R33 |
For technical issues E-mail OER Webmaster